Schedule 13D ownership disclosure

THESEUS PHARMACEUTICALS INC

Security class unavailable · CUSIP: 88369M101

Event date: 2023-12-22

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
7.3000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001214659-23-016936
Form type
SC 13D/A
Filer
TANG CAPITAL PARTNERS LP
CIK
CIK 1191935
Filed
Dec 28, 2023
Reporting period
Dec 22, 2023
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub